-transparent.png){kind=logo}
BACKGROUND Nocturnal airway narrowing is a common problem for patients with asthma but the role of inflammation in its pathogenesis is unclear. Overnight changes in airway inflammatory cell populations were studied in patients with nocturnal asthma and in control normal subjects. METHODS Bronchoscopies were performed at 0400 hours and 1600 hours in eight healthy subjects and in 10 patients with nocturnal asthma (> 15% overnight fall in peak flow plus at least one awakening/week with asthma). The two bronchoscopies were separated by at least five days, and both the order of bronchoscopies and site of bronchoalveolar lavage (middle lobe or lingula with contralateral lower lobe bronchial biopsy) were randomised. RESULTS In the normal subjects there was no difference in cell numbers and differential cell counts in bronchoalveolar lavage fluid between 0400 and 1600 hours, but in the nocturnal asthmatic subjects both eosinophil counts (median 0.11 x 10(5) cells/ml at 0400 hours, 0.05 x 10(5) cells/ml at 1600 hours) and lymphocyte numbers (0.06 x 10(5) cells/ml at 0400 hours, 0.03 x 10(5) cells/ml at 1600 hours) increased at 0400 hours, along with an increase in eosinophil cationic protein levels in bronchoalveolar lavage fluid (3.0 micrograms/ml at 0400 hours, 2.0 micrograms/l at 1600 hours). There were no changes in cell populations in the bronchial biopsies or in alveolar macrophage production of hydrogen peroxide, GM-CSF, or TNF alpha in either normal or asthmatic subjects at 0400 and 1600 hours. There was no correlation between changes in overnight airway function and changes in cell populations in the bronchoalveolar lavage fluid. CONCLUSIONS This study confirms that there are increases in inflammatory cell populations in the airway fluid at night in asthmatic but not in normal subjects. The results have also shown a nocturnal increase in eosinophil cationic protein levels in bronchoalveolar lavage fluid, but these findings do not prove that these inflammatory changes cause nocturnal airway narrowing.
T W Mackay, and
W A Wallace, and
S E Howie, and
P H Brown, and
A P Greening, and
M K Church, and
N J Douglas
November 1994,
American journal of respiratory and critical care medicine,
T W Mackay, and
W A Wallace, and
S E Howie, and
P H Brown, and
A P Greening, and
M K Church, and
N J Douglas
February 1991,
The American review of respiratory disease,
T W Mackay, and
W A Wallace, and
S E Howie, and
P H Brown, and
A P Greening, and
M K Church, and
N J Douglas
October 1995,
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
T W Mackay, and
W A Wallace, and
S E Howie, and
P H Brown, and
A P Greening, and
M K Church, and
N J Douglas
September 1999,
Chronobiology international,
T W Mackay, and
W A Wallace, and
S E Howie, and
P H Brown, and
A P Greening, and
M K Church, and
N J Douglas
January 1986,
Respiration; international review of thoracic diseases,
T W Mackay, and
W A Wallace, and
S E Howie, and
P H Brown, and
A P Greening, and
M K Church, and
N J Douglas
December 1992,
The American review of respiratory disease,
T W Mackay, and
W A Wallace, and
S E Howie, and
P H Brown, and
A P Greening, and
M K Church, and
N J Douglas
December 1998,
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
T W Mackay, and
W A Wallace, and
S E Howie, and
P H Brown, and
A P Greening, and
M K Church, and
N J Douglas
April 1974,
North Carolina medical journal,
T W Mackay, and
W A Wallace, and
S E Howie, and
P H Brown, and
A P Greening, and
M K Church, and
N J Douglas
September 1992,
Clinics in chest medicine,
T W Mackay, and
W A Wallace, and
S E Howie, and
P H Brown, and
A P Greening, and
M K Church, and
N J Douglas
January 2007,
Current opinion in pulmonary medicine,
